Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease

被引:74
|
作者
Zilberter, Misha [1 ]
Ivanov, Anton [2 ,3 ]
Ziyatdinova, Sofya [4 ]
Mukhtarov, Marat [2 ,3 ]
Malkov, Anton [2 ,3 ]
Alpar, Alan [1 ,8 ]
Tortoriello, Giuseppe [1 ,8 ]
Botting, Catherine H. [5 ]
Fueloep, Livia [9 ]
Osypov, Alex A. [6 ]
Pitkanen, Asla [4 ,7 ]
Tanila, Heikki [4 ,7 ]
Harkany, Tibor [1 ,8 ]
Zilberter, Yuri [2 ,3 ]
机构
[1] Karolinska Inst, Stockholm, Sweden
[2] Inst Neurosci Syst, INSERM UMR1106, Marseille, France
[3] Aix Marseille Univ, Marseille, France
[4] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland
[5] Univ St Andrews, Sch Chem, St Andrews, Fife, Scotland
[6] Inst Cell Biophys RAS, Pushchino, Russia
[7] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
[8] Univ Aberdeen, European Neurosci Inst Aberdeen, Aberdeen AB9 1FX, Scotland
[9] Univ Szeged, Hungarian Acad Sci, Dept Med Chem, Szeged, Hungary
基金
芬兰科学院;
关键词
beta-amyloid; Alzheimer's disease; energy metabolism; energy substrates; epilepsy; neuronal excitability; SUPRACHIASMATIC NUCLEUS NEURONS; MILD COGNITIVE IMPAIRMENT; TEMPORAL-LOBE EPILEPSY; AMYLOID-BETA; OXIDATIVE STRESS; BRAIN GLYCOGEN; A-BETA; HIPPOCAMPAL HYPERACTIVITY; METABOLIC DYSFUNCTION; GLUCOSE-METABOLISM;
D O I
10.1111/jnc.12127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deficient energy metabolism and network hyperactivity are the early symptoms of Alzheimer's disease (AD). In this study, we show that administration of exogenous oxidative energy substrates (OES) corrects neuronal energy supply deficiency that reduces the amyloid-beta-induced abnormal neuronal activity in vitro and the epileptic phenotype in AD model in vivo. In vitro, acute application of protofibrillar amyloid-142 (A142) induced aberrant network activity in wild-type hippocampal slices that was underlain by depolarization of both the neuronal resting membrane potential and GABA-mediated current reversal potential. A142 also impaired synaptic function and long-term potentiation. These changes were paralleled by clear indications of impaired energy metabolism, as indicated by abnormal NAD(P)H signaling induced by network activity. However, when glucose was supplemented with OES pyruvate and 3-beta-hydroxybutyrate, A142 failed to induce detrimental changes in any of the above parameters. We administered the same OES as chronic supplementation to a standard diet to APPswe/PS1dE9 transgenic mice displaying AD-related epilepsy phenotype. In the ex-vivo slices, we found neuronal subpopulations with significantly depolarized resting and GABA-mediated current reversal potentials, mirroring abnormalities we observed under acute A1-42 application. Ex-vivo cortex of transgenic mice fed with standard diet displayed signs of impaired energy metabolism, such as abnormal NAD(P)H signaling and strongly reduced tolerance to hypoglycemia. Transgenic mice also possessed brain glycogen levels twofold lower than those of wild-type mice. However, none of the above neuronal and metabolic dysfunctions were observed in transgenic mice fed with the OES-enriched diet. In vivo, dietary OES supplementation abated neuronal hyperexcitability, as the frequency of both epileptiform discharges and spikes was strongly decreased in the APPswe/PS1dE9 mice placed on the diet. Altogether, our results suggest that early AD-related neuronal malfunctions underlying hyperexcitability and energy metabolism deficiency can be prevented by dietary supplementation with native energy substrates. Read the Editorial Highlight for this article on doi: 10.1111/jnc.12138.
引用
收藏
页码:157 / 171
页数:15
相关论文
共 50 条
  • [41] Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer’s disease
    C Yi
    X Mei
    P Ezan
    S Mato
    I Matias
    C Giaume
    A Koulakoff
    Cell Death & Differentiation, 2016, 23 : 1691 - 1701
  • [42] Osteoporosis in a Mouse Model of Alzheimer's Disease
    Jung, Younghun
    Ay, Birol
    Cyr, Sajin
    Tognoni, Christina
    Klovdahl, Kaitlin
    Matthias, Julia
    Cui, Quixa
    Bouxsein, Mary
    Carreras, Isabel
    Dedeoglu, Alpaslan
    Bastepe, Murat
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 50 - 50
  • [43] A geroscience mouse model for Alzheimer's disease
    Darvas, Martin
    Keene, Dirk
    Ladiges, Warren
    PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES, 2019, 9
  • [44] Neuronal activity and early neurofibrillary tangles in Alzheimer's disease
    Hatanpaa, K
    Brady, DR
    Stoll, J
    Rapoport, SI
    Chandrasekaran, K
    ANNALS OF NEUROLOGY, 1996, 40 (03) : 411 - 420
  • [45] Lactate Deficit in an Alzheimer Disease Mouse Model: The Relationship With Neuronal Damage
    Zhang, Mao
    Cheng, Xiaofang
    Dang, Ruozhi
    Zhang, Weiwei
    Zhang, Jie
    Yao, Zhongxiang
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (12): : 1163 - 1176
  • [46] Hyperactivity of medial prefrontal cortex pyramidal neurons occurs in a mouse model of early-stage Alzheimer's disease without β-amyloid accumulation
    Choudhury, Nasreen
    Chen, Lihua
    Al-Harthi, Lena
    Hu, Xiu-Ti
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease
    Xu, Wenjin
    Fitzgerald, Shane
    Nixon, Ralph A.
    Levy, Efrat
    Wilson, Donald A.
    EXPERIMENTAL NEUROLOGY, 2015, 264 : 82 - 91
  • [48] Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model
    Walker, Jennifer M.
    Klakotskaia, Diana
    Ajit, Deepa
    Weisman, Gary A.
    Wood, W. Gibson
    Sun, Grace Y.
    Serfozo, Peter
    Simonyi, Agnes
    Schachtman, Todd R.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 561 - 572
  • [49] Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease
    Wang, Shengyuan
    Cu, Yu
    Wang, Chao
    Xie, Wei
    Ma, Lan
    Zhu, Jinfeng
    Zhang, Yan
    Dang, Rui
    Wang, Decai
    Wu, Yonghui
    Wu, Qunhong
    PLOS ONE, 2015, 10 (11):
  • [50] Mechanisms of Alzheimer's disease. Neuronal hyperactivity and hypoactivity as new therapeutic targets
    Busche, M. A.
    Staufenbiel, M.
    Willem, M.
    Haass, C.
    Foerstl, H.
    NERVENARZT, 2016, 87 (11): : 1163 - 1174